Shahinfar Shahnaz | Merck & Co. Inc.
スポンサーリンク
概要
関連著者
-
Kurokawa K
Research Center For Advanced Science And Technology Of The University Of Tokyo
-
KEANE William
Merck & Co., Inc.
-
SHAHINFAR Shahnaz
Merck & Co., Inc.
-
Keane William
Merck & Co. Inc.
-
KUROKAWA Kiyoshi
Research Center for Advanced Science and Technology of the University of Tokyo
-
Shahinfar Shahnaz
Merck & Co. Inc.
-
Cooper Mark
Diabetes And Metabolism Division Baker Heart Research Institute
-
Wieland Kenneth
Merck & Co. Inc.
-
Lyle Paulette
Merck & Co. Inc.
-
Chan Juliana
Department Of Medicine And Therapeutics Prince Of Wales Hospital The Chinese University Of Hong Kong
-
KUROKAWA Kiyoshi
Institute of Medical Sciences, Tokai University School of Medicine
-
SMITH Thomas
Merck & Co., Inc.
-
BRENNER Barry
Department of Medicine, Renal Division, Brigham and Women's Hospital and Harvard Medical School
-
Brenner Barry
Department Of Medicine Renal Division Brigham And Women's Hospital And Harvard Medical School
-
Smith Thomas
Merck & Co. Inc.
-
ZHANG Zhongxin
Merck & Co., Inc.
-
Kurokawa Kiyoshi
Institute Of Medical Sciences Tokai University
-
Zhang Zhongxin
Merck & Co. Inc.
-
CHAN Juliana
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, The Prince of Wales Hospital
著作論文
- Treatment of type 2 diabetic patients with kidney disease with AT_1-receptor antagonists : lessons from recent trials
- Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes : a subanalysis of Japanese patients from the RENAAL study